1
|
Couñago-Fernández M, Otero P, Samartín-Ucha M, Paradela-Carreiro A, Muniategui-Lorenzo S, Martínez-López de Castro N. Predicted concentrations of antineoplastic drugs in the aquatic environment: The case of Ría de Vigo (NW, Spain). MARINE POLLUTION BULLETIN 2024; 203:116399. [PMID: 38703630 DOI: 10.1016/j.marpolbul.2024.116399] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/07/2024] [Revised: 04/16/2024] [Accepted: 04/18/2024] [Indexed: 05/06/2024]
Abstract
The European Medicines Agency (EMA) mandates Environmental Risk Assessments (ERAs) since 2006 to determine potential risks of new marketed medicines. Drugs with a Predicted Environmental Concentration (PEC) in inland surface waters exceeding 0.01 μg L-1 require further environmental risk assessment. PEC may be refined based on prevalence data and/or based on the treatment regimen. In this study, based on EMA regulations, refined PEC of 108 antineoplastic drugs in coastal waters were determined based on the consumption in a coastal health area during 2021, identifying six drugs with potential environmental risk in surface waters (hydroxyurea, capecitabine, abiraterone, ibrutinib, imatinib and 5-fluorouracil) and two in marine ecosystem (hydroxyurea and capecitabine). Comparison of these refined PECs with data from marketing laboratories revealed significant disparities, suggesting the need for regular updates, especially with changes in drug indications or financing. Notably, the identified drugs are not yet on the main reference lists of emerging contaminants.
Collapse
Affiliation(s)
| | - Pablo Otero
- Centro Oceanográfico de Vigo, Instituto Español de Oceanografía (IEO, CSIC), Subida a Radio Faro 50, Vigo 36390, Spain
| | - Marisol Samartín-Ucha
- Pharmacy Service, Complexo Hospitalario Universitario de Vigo, Área Sanitaria de Vigo, Spain; Innovation in Clinical Pharmacy Research Group (i-FARMA-Vigo), Galicia Sur Health Research Institute (IIS Galicia Sur) SERGAS-UVIGO, Vigo, Spain
| | - Adolfo Paradela-Carreiro
- Pharmacy Service, Complexo Hospitalario Universitario de Vigo, Área Sanitaria de Vigo, Spain; Innovation in Clinical Pharmacy Research Group (i-FARMA-Vigo), Galicia Sur Health Research Institute (IIS Galicia Sur) SERGAS-UVIGO, Vigo, Spain
| | - Soledad Muniategui-Lorenzo
- University of A Coruña, Group of Applied Analytical Chemistry, University Institute of Environment (IUMA), A Coruña 15071, Spain
| | - Noemí Martínez-López de Castro
- Pharmacy Service, Complexo Hospitalario Universitario de Vigo, Área Sanitaria de Vigo, Spain; Innovation in Clinical Pharmacy Research Group (i-FARMA-Vigo), Galicia Sur Health Research Institute (IIS Galicia Sur) SERGAS-UVIGO, Vigo, Spain
| |
Collapse
|
2
|
Manavi MA, Fathian Nasab MH, Mohammad Jafari R, Dehpour AR. Mechanisms underlying dose-limiting toxicities of conventional chemotherapeutic agents. J Chemother 2024:1-31. [PMID: 38179685 DOI: 10.1080/1120009x.2023.2300217] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/20/2023] [Accepted: 12/21/2023] [Indexed: 01/06/2024]
Abstract
Dose-limiting toxicities (DLTs) are severe adverse effects that define the maximum tolerated dose of a cancer drug. In addition to the specific mechanisms of each drug, common contributing factors include inflammation, apoptosis, ion imbalances, and tissue-specific enzyme deficiencies. Among various DLTs are bleomycin-induced pulmonary fibrosis, doxorubicin-induced cardiomyopathy, cisplatin-induced nephrotoxicity, methotrexate-induced hepatotoxicity, vincristine-induced neurotoxicity, paclitaxel-induced peripheral neuropathy, and irinotecan, which elicits severe diarrhea. Currently, specific treatments beyond dose reduction are lacking for most toxicities. Further research on cellular and molecular pathways is imperative to improve their management. This review synthesizes preclinical and clinical data on the pharmacological mechanisms underlying DLTs and explores possible treatment approaches. A comprehensive perspective reveals knowledge gaps and emphasizes the need for future studies to develop more targeted strategies for mitigating these dose-dependent adverse effects. This could allow the safer administration of fully efficacious doses to maximize patient survival.
Collapse
Affiliation(s)
- Mohammad Amin Manavi
- Experimental Medicine Research Center, Tehran University of Medical Sciences, Tehran, Iran
- Department of Pharmacology and Toxicology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
| | | | - Razieh Mohammad Jafari
- Experimental Medicine Research Center, Tehran University of Medical Sciences, Tehran, Iran
- Department of Pharmacology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
| | - Ahmad Reza Dehpour
- Experimental Medicine Research Center, Tehran University of Medical Sciences, Tehran, Iran
- Department of Pharmacology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
| |
Collapse
|
3
|
Alzola-Andrés M, Domingo-Echaburu S, Segura Y, Valcárcel Y, Orive G, Lertxundi U. Pharmaceuticals in hospital wastewaters: an analysis of the UBA's pharmaceutical database. ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH INTERNATIONAL 2023; 30:99345-99361. [PMID: 37610546 DOI: 10.1007/s11356-023-29214-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/02/2023] [Accepted: 08/03/2023] [Indexed: 08/24/2023]
Abstract
The presence of pharmaceuticals in hospital wastewaters (HWW) has been a focus of interest for researchers in the last decades. Certain therapeutic classes, such as X-ray contrast media, broad-spectrum antimicrobials and cytotoxics among others, are mainly used in hospitals-health care facilities. This study is focused on available studies monitoring the presence of pharmaceuticals in HWW around the world. To that end, the last available version (v3. 2021) of the "Pharmaceuticals in the Environment" database published by the Federal German Environment Agency (Umweltbundesamt) has been used. Almost half of all studies included (107) have been conducted in Europe. Pharmaceuticals have been monitored in HWW in 38 different countries across all five continents. The country with the greatest number of studies is Brazil (11), followed by Spain (8), China (7), and France (6). Our analysis revealed that 271 different pharmaceuticals have been detected at least once in HWW. The five drugs with more studies showing a positive detection are ciprofloxacin (38), sulfamethoxazole (36), diclofenac (34), ibuprofen (29), and trimethoprim (27). A total of 47 out of 271 drugs are considered in the NIOSH "Hazardous drug" list. However, monitoring data for some widely used drugs in hospital settings such as muscle relaxants, anesthetics, and antidotes is lacking. In conclusion, this study provides the first large-scale metadata analysis for the pharmaceuticals in HWW worldwide.
Collapse
Affiliation(s)
- Maitane Alzola-Andrés
- School of Pharmacy, NanoBioCel Group, Laboratory of Pharmaceutics, School of Pharmacy, University of the Basque Country UPV/EHU, Paseo de la Universidad 7, 01006, Vitoria-Gasteiz, Spain
| | - Saioa Domingo-Echaburu
- Osakidetza Basque Health Service, Debagoiena Integrated Health Organisation, Pharmacy Service, Nafarroa Hiribidea 16, 20500, Arrasate, Gipuzkoa, Spain
| | - Yolanda Segura
- Chemical and Environmental Technology Department, University Rey Juan Carlos, Avenida Tulipan s/n, 28933, Mostoles, Madrid, Spain
| | - Yolanda Valcárcel
- Health and Environment Risk Assessment Group, (RiSAMA), University Rey Juan Carlos, Avda Tulipán sn, Móstoles, Madrid, Spain
- Department of Medical Specialties and Public Health, Faculty of Health Sciences, Rey Juan Carlos University, Avda. Atenas s/n, 28922 Alcorcón, Madrid, Spain
| | - Gorka Orive
- NanoBioCel Group, Laboratory of Pharmaceutics, School of Pharmacy, University of the Basque Country UPV/EHU, Paseo de la Universidad 7, 01006, Vitoria-Gasteiz, Spain
- Biomedical Research Networking Centre in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Vitoria-Gasteiz, Spain
- University Institute for Regenerative Medicine and Oral Implantology - UIRMI (UPV/EHU-Fundación Eduardo Anitua), Vitoria, Spain
- Bioaraba, NanoBioCel Research Group, Vitoria-Gasteiz, Spain
| | - Unax Lertxundi
- Bioaraba Health Research Institute, Osakidetza Basque Health Service, Araba Mental Health Network, Araba Psychiatric Hospital, Pharmacy Service, c/Alava 43, 01006, Vitoria-Gasteiz, Álava, Spain.
| |
Collapse
|
4
|
Zolgharnein J, Goudarzy F, Ghasemi JB. A New Sensitive Fluorescence Sensor and Photocatalyst for Determination and Degradation of Sodium Valproate Using g-C3N4@Fe3O4@CuWO4 Nanocomposite and FCCD Optimization. J Fluoresc 2023; 33:1777-1801. [PMID: 36826727 DOI: 10.1007/s10895-023-03168-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/23/2022] [Accepted: 02/03/2023] [Indexed: 02/25/2023]
Abstract
In this research, carbon nitride nanocomposite coupled with Fe3O4 and CuWO4 was thermally synthesized and characterized by different techniques, including SEM, TEM, XRD, EDX, and FTIR. Due to sodium valproate's luminescence quenching of this nanocomposite, a reliable, accurate, sensitive, selective, and fast-acting sodium valproate assay was proposed. Optimization of this fluorescent sensor was carried out by the FCCD approach. In the optimum conditions, the plot of sodium valproate concentration versus nanocomposite fluorescence emission showed a linear response (R2 = 0.9918), with a range of 0-0.55 µM, the limit of detection (S/N = 3) equal to 0.85 nM and limit of qualification equal to 2.82 nM. Photocatalytic activity of g-C3N4@Fe3O4@CuWO4 (40%) nanocomposite exhibited a good potency to sodium valproate degradation. Active species of degradation including superoxide radicals, holes, and hydroxyl radicals were investigated using ammonium oxalate, benzoquinone, and 2-propanol to identify the mechanism of photodegradation action. The activity of benzoquinone in the photocatalytic process led to a reduction in the rate of analyte degradation, which indicates the prominent role of superoxide radicals compared to other species in the degradation process. The degradation rate of the analyte using the Fenton reagent was found to be around two times more than in the Fenton reagent-free process. The possible mechanism for the fluorescence sensor and photocatalytic degradation reaction was also discussed.
Collapse
Affiliation(s)
- J Zolgharnein
- Department of Chemistry, Faculty of Sciences, Arak University, P.O. Box 38156-8-8394, Arak, I.R., Iran.
| | - F Goudarzy
- Department of Chemistry, Faculty of Sciences, Arak University, P.O. Box 38156-8-8394, Arak, I.R., Iran
| | - J B Ghasemi
- School of Chemistry, University College of Science, University of Tehran, P.O. Box 14155-6455, Tehran, I.R., Iran.
| |
Collapse
|
5
|
Abajo Z, Jimenez A, Domingo-Echaburu S, Valcárcel Y, Segura Y, Orive G, Lertxundi U. Analyzing the potential environmental impact of NIOSH list of hazardous drugs (group 2). THE SCIENCE OF THE TOTAL ENVIRONMENT 2023; 873:162280. [PMID: 36822426 DOI: 10.1016/j.scitotenv.2023.162280] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/20/2022] [Revised: 02/12/2023] [Accepted: 02/12/2023] [Indexed: 06/18/2023]
Abstract
For the first time, several pharmaceuticals have been defined as priority substances in the new proposal of the revision of the Water Framework Directive (WFD). Consequently, environmental quality standards have been determined for several drugs. This is the case with the antiepileptic carbamazepine, which is considered as hazardous in healthcare settings by The National Institute for Occupational Safety and Health (NIOSH). This organism considers as such drugs that have shown teratogenicity, carcinogenicity, genotoxicity or other developmental, reproductive, or organ toxicity at low doses in studies with animals or humans. This study has been focused on the non-carcinogenic drugs classified in group 2, and their presence in the environment. This group contains many different therapeutic agents such as antineoplastics, psychoactive drugs, immunosuppressants and antivirals, among others. Of the 116 drugs included in the list, 26 have been found in aquatic environmental matrices. Certain drugs have received most attention (e.g., the antiepileptic carbamazepine, progesterone and the antidepressant paroxetine) while others completely lack environmental monitoring. Carbamazepine, fluconazole, paroxetine and warfarin have been found in invertebrates' tissues, whereas carbamazepine, oxazepam and paroxetine have been found in fish tissues. The main aim of the NIOSH's hazardous drug list is to inform healthcare professionals about adequate protection measures to prevent occupational exposure to these pharmaceuticals. However, this list contains useful information for other professionals and researchers such as environmental scientists. The paucity of relevant environmental data of certain hazardous pharmaceuticals might be important to help in the prioritization of compounds that may demand further research.
Collapse
Affiliation(s)
- Z Abajo
- Bioaraba Health Research Institute
| | - A Jimenez
- School of Pharmacy, University of the Basque Country
| | - S Domingo-Echaburu
- Osakidetza Basque Health Service, Debagoiena Integrated Health Organisation, Pharmacy Service, Nafarroa Hiribidea 16, 20500 Arrasate, Gipuzkoa, Spain
| | - Y Valcárcel
- Health and Environment Risk Assessment Group, (RiSAMA), University Rey Juan Carlos, Avda Tulipán sn, Móstoles, Madrid, Spain; Department of Medical Specialties and Public Health, Faculty of Health Sciences, Rey Juan Carlos University, Avda. Atenas s/n, 28922, Alcorcón, Madrid, Spain
| | - Y Segura
- Chemical and Environmental Technology Department, University Rey Juan Carlos, 28933 Madrid, Spain
| | - G Orive
- NanoBioCel Group, Laboratory of Pharmaceutics, School of Pharmacy, University of the Basque Country UPV/EHU, Paseo de la Universidad 7, Vitoria-Gasteiz 01006, Spain; Biomedical Research Networking Centre in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Vitoria-Gasteiz, Spain; University Institute for Regenerative Medicine and Oral Implantology-UIRMI (UPV/EHU-Fundación Eduardo Anitua), Vitoria, Spain; Singapore Eye Research Institute, The Academia, 20 College Road, Discovery Tower, Singapore; Bioaraba, NanoBioCel Research Group, Vitoria-Gasteiz, Spain.
| | - U Lertxundi
- Bioaraba Health Research Institute, Vitoria-Gasteiz, Spain. Osakidetza Basque Health Service, Araba Mental Health Network, Araba Psychiatric Hospital, Pharmacy Service, c/Alava 43, 01006 Vitoria-Gasteiz, Álava, Spain.
| |
Collapse
|
6
|
Lertxundi U, Orive G. Por una farmacia más sostenible. FARMACIA HOSPITALARIA 2023; 47:53-54. [PMID: 36801093 DOI: 10.1016/j.farma.2023.01.005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/26/2022] [Revised: 01/02/2023] [Accepted: 01/17/2023] [Indexed: 05/19/2023] Open
Affiliation(s)
- Unax Lertxundi
- Instituto de Investigación Sanitaria Bioaraba, Osakidetza-Servicio Vasco de Salud, Red Araba de Salud Mental, Servicio de Farmacia, Hospital Psiquiátrico Araba, Vitoria-Gasteiz, España.
| | - Gorka Orive
- Grupo NanoBioCel, Laboratorio de Farmacia, Facultad de Farmacia, Universidad del País Vasco, Vitoria-Gasteiz, España; Centro de Investigación Biomédica en Red de Bioingeniería, Biomateriales y Nanomedicina Nanomedicina (CIBER-BBN), Vitoria-Gasteiz, España; Instituto Universitario de Medicina Regenerativa e Implantología Oral, Vitoria-Gasteiz, España; Instituto de Investigación Ocular de Singapur, Singapur; Grupo de Investigación NanoBioCel, Bioaraba, Vitoria-Gasteiz, España
| |
Collapse
|
7
|
Zeng Z, Deng Z, Wang T, Huang H, Guo Y. Environmentally friendly synthesis of S-scheme heterojunction UiO-66-NH2/Bi7O9I3 for promoted degradation of ciprofloxacin under visible light: DFT calculation, degradation mechanism and toxicity evaluation. Sep Purif Technol 2023. [DOI: 10.1016/j.seppur.2023.123264] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/26/2023]
|
8
|
Peng Y, Li M, Jia X, Su J, Zhao X, Zhang S, Zhang H, Zhou X, Chen J, Huang Y, Wågberg T, Hu G. Cu Nanoparticle-Decorated Boron-Carbon-Nitrogen Nanosheets for Electrochemical Determination of Chloramphenicol. ACS APPLIED MATERIALS & INTERFACES 2022; 14:28956-28964. [PMID: 35704422 DOI: 10.1021/acsami.2c06729] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/15/2023]
Abstract
In the present work, irregular Cu nanoparticle-decorated boron-carbon-nitrogen (Cu-BCN) nanosheets were successfully synthesized. A Cu-BCN dispersion was deposited on a bare glassy carbon electrode (GCE) to prepare an electrochemical sensor (Cu-BCN/GCE) for the detection of chloramphenicol (CAP) in the environment. Cu-BCN was characterized using high-resolution scanning transmission electron microscopy (HRSTEM), scanning electron microscopy (SEM), X-ray diffraction (XRD) analysis, and X-ray photoelectron spectroscopy (XPS). The performance of the Cu-BCN/GCE was studied using electrochemical impedance spectroscopy (EIS), and its advantages were proven by electrode comparison. Differential pulse voltammetry (DPV) was used to optimize the experimental conditions, including the amount of Cu-BCN deposited, enrichment potential, deposition time, and pH of the electrolyte. A linear relationship between the CAP concentration and current response was obtained under the optimized experimental conditions, with a wide linear range and a limit of detection (LOD) of 2.41 nmol/L. Cu-BCN/GCE exhibited high stability, reproducibility, and repeatability. In the presence of various organic and inorganic species, the influence of the Cu-BCN-based sensor on the current response of CAP was less than 5%. Notably, the prepared sensor exhibited excellent performance in real-water samples, with satisfactory recovery.
Collapse
Affiliation(s)
- Yan Peng
- College of Eco-Environmental Engineering, Guizhou Minzu University, Guiyang 550025, China
| | - Meng Li
- College of Eco-Environmental Engineering, Guizhou Minzu University, Guiyang 550025, China
- College of Chemistry, Zhengzhou University, Zhengzhou 450000, China
| | - Xiuxiu Jia
- Institute for Ecological Research and Pollution Control of Plateau Lakes, School of Ecology and Environmental Science, Yunnan University, Kunming 650504, China
| | - Jianru Su
- College of Eco-Environmental Engineering, Guizhou Minzu University, Guiyang 550025, China
| | - Xue Zhao
- College of Chemistry and Molecular Sciences, Wuhan University, Wuhan 430072, China
| | - Shusheng Zhang
- College of Chemistry, Zhengzhou University, Zhengzhou 450000, China
| | - Haibo Zhang
- College of Chemistry and Molecular Sciences, Wuhan University, Wuhan 430072, China
| | - Xiaohai Zhou
- College of Chemistry and Molecular Sciences, Wuhan University, Wuhan 430072, China
| | - Jianbing Chen
- Research Academy of Non-metallic Mining Industry Development, Materials and Environmental Engineering College, Chizhou University, Chizhou 247000, China
| | - Yimin Huang
- Institute for Ecological Research and Pollution Control of Plateau Lakes, School of Ecology and Environmental Science, Yunnan University, Kunming 650504, China
| | - Thomas Wågberg
- Department of Physics, Umeå University, Umeå S-901 87, Sweden
| | - Guangzhi Hu
- Institute for Ecological Research and Pollution Control of Plateau Lakes, School of Ecology and Environmental Science, Yunnan University, Kunming 650504, China
- Department of Physics, Umeå University, Umeå S-901 87, Sweden
| |
Collapse
|